Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATHOS: Risk-stratified, reduced-intensity adjuvant treatment after transoral surgery for HPV-positive oropharyngeal cancer
2014-003392-32Phase 2Unknown
- Sponsor
- Velindre University NHS Trust
- Start
- Aug 2014
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin and carboplatin in oropharyngeal squamous cell carcinoma (OPSCC) (3 arms), sponsored by Velindre University NHS Trust. Primary endpoint: Swallowing function at 12 months. Status: unknown.
02
Drugs
cisplatincarboplatin
03
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)
Beyond the preview
Go deeper on 2014-003392-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003392-32.